A recent meta-analysis identified HMGB1 (high mobility group box 1) as a potential biomarker for HCC diagnosis, as it is significantly overexpressed at mRNA and protein level in HCC tissue samples, when compared with normal liver [19]. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.